Randomised controlled trial of gabpentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379]

BMC Neurology

Volumn 4, Issue , 2004, Pages

  van de Vusse, Anton C ^a   Stomp van den Berg, Suzanne G M ^a   Kessels, Alfons H F ^a   Weber, Wim E J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; GABAPENTIN; PLACEBO; 4 AMINOBUTYRIC ACID; AMINE; ANALGESIC AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;

ADULT; AGED; ALLODYNIA; ANALGESIC ACTIVITY; ARTICLE; CLINICAL TRIAL; COMPLEX REGIONAL PAIN SYNDROME TYPE I; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG EFFICACY; FEMALE; FOLLOW UP; GAIT DISORDER; HEADACHE; HUMAN; LETHARGY; LIMB PAIN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PAIN ASSESSMENT; POPULATION RESEARCH; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SENSORY DYSFUNCTION; SIDE EFFECT; SOMNOLENCE; STATISTICAL ANALYSIS; STOMACH DISEASE; VISUAL ANALOG SCALE; WATER RETENTION; MIDDLE AGED; PAIN; PATHOPHYSIOLOGY; SICKNESS IMPACT PROFILE; SOMATOSENSORY DISORDER;

ADULT; AGED; AMINES; ANALGESICS; CROSS-OVER STUDIES; CYCLOHEXANECARBOXYLIC ACIDS; DOUBLE-BLIND METHOD; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; REFLEX SYMPATHETIC DYSTROPHY; SICKNESS IMPACT PROFILE; SOMATOSENSORY DISORDERS;

EID: 12944300193     PISSN: 14712377     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2377-4-13     Document Type: Article

References (45)

1. Veldman PH, Reynen HM, Arntz IE, Goris RJ: Signs and symptoms of reflex sympathetic dystrophy: Prospective study of 829 patients. Lancet 1993, 342:1012-1016.
2. Marchettini P, Lacerenza M, Ieracitano D, Canal N: Sensitized nociceptors in reflex sympathetic dystrophies. Funct Neurol 1989, 4:135-140.
3. Mackin G: Medical and pharmacologic management of upper extremity neuropathic pain syndromes. J Hand Ther 1997, 10: 96-109.
4. Jänig W: The puzzle of "reflex sympathetic dystrophy": Mechanisms, hypotheses, open questions. In: Reflex sympathetic dystrophy. A reappraisal. 6 6 Edited by: Jänig W, Stanton-Hicks M. Seattle: IASP Press; 1996:1-24.
5. Sindrup S, Jensen T: Pharmacologic treatment of pain in polyneuropathy. Neurology 2000, 55:915-920.
6. Tremont-Lukats IW, Megeff C, Backonja MM: Anticonvulsants for neuropathic pain syndromes: Mechanisms of action and place in therapy. Drugs 2000, 60:1029-1052.
7. Pandey CK, Bose N, Garg G, Singh N, Baronia A, Agarwal A, Singh PK, Singh U: Gabapentin for the treatment of pain in guillainbarre syndrome: A double-blinded, placebo-controlled, crossover study. Anesth Analg 2002, 95:1719-1723. table of contents
8. Serpell MG: Gabapentin in neuropathic pain syndromes: A randomised, double-blind, placebo-controlled trial. Pain 2002, 99:557-566.
9. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus Miller L: Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. JAMA 1998, 280:1837-1842.
10. Tai Q, Kirshblum S, Chen B, Millis S, Johnston M, DeLisa JA: Gabapentin in the treatment of neuropathic pain after spinal cord injury: A prospective, randomized, double-blind, crossover trial. J Spinal Cord Med 2002, 25:100-105.
11. Mellegers MA, Furlan AD, Mailis A: Gabapentin for neuropathic pain: Systematic review of controlled and uncontrolled literature. Clin J Pain 2001, 17:284-295.
12. Morello CM, Leckband SG, Stoner CP, Moorhouse DF, Sahagian GA: Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 1999, 159:1931-1937.
13. Bone M, Critchley P, Buggy DJ: Gabapentin in postamputation phantom limb pain: A randomized, double-blind, placebo-controlled, cross-over study. Reg Anesth Pain Med 2002, 27:481-486.
14. Garcia-Borreguero D, Larrosa O, de la Llave Y, Verger K, Masramon X, Hernandez G: Treatment of restless legs syndrome with gabapentin: A double-blind, cross-over study. Neurology 2002, 59:1573-1579.
15. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E: Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. Jama 1998, 280:1831-1836.
16. Navani A, Rusy LM, Jacobson RD, Weisman SJ: Treatment of tremors in complex regional pain syndrome. J Pain Symptom Manage 2003, 25:386-390.
17. Stevens RA, Powar M, Stotz A, Barclay J, Kolbusz M: Gabapentin as an analgesic in crps, type i. Regional anesthesia and pain medicine 1999, 24(31):32.
18. Mellick GA, Mellick LB: Reflex sympathetic dystrophy treated with gabapentin. Arch Phys Med Rehabil 1997, 78: 8-105.
19. Mellick GA, Mellicy LB, Mellick LB: Gabapentin in the management of reflex sympathetic dystrophy. J Pain Symptom Manage 1995, 10:265-266.
20. Mellick LB, Mellick GA: Successful treatment of reflex sympathetic dystrophy with gabapentin. Am J Emerg Med 1995, 13:96.
21. Scheinfeld N: The role of gabapentin in treating diseases with cutaneous manifestations and pain. Int J Dermatol 2003, 42:491-495.
22. Jagustyn P, Romaniak A: [gabapentin - new therapeutic possibilities]. Neurol Neurochir Pol 2002, 36:971-980.
23. Block F: [gabapentin for therapy of neuropathic pain]. Schmerz 2001, 15:280-288.
24. Block F: [gabapentin therapy for pain]. Nervenarzt 2001, 72:69-77.
25. Tong HC, Nelson VS: Recurrent and migratory reflex sympathetic dystrophy in children. Pediatr Rehabil 2000, 4: 7-89.
26. Rovetta G, Baratto L, Monteforte P: Low dose gabapentin for shoulder-hand syndrome induced by phenobarbital: A threemonth study. Drugs Exp Clin Res 1999, 25:185-191.
27. Wheeler DS, Vaux KK, Tam DA: Use of gabapentin in the treatment of childhood reflex sympathetic dystrophy. Pediatr Neurol 2000, 22:220-221.
28. Forouzanfar T, van Kleef M, Weber W: Radiofrequency lesions of the stellate ganglion in chronic pain syndromes: Retrospective analysis of clinical efficacy in 86 patients. Clin J Pain 2000, 16:164-168.
29. Goris R: Treatment of reflex sympathetic dystrophy with hydroxyl radical scavengers. Unfallchirurg 1985, 88: 30-332.
30. Zyluk A: The reasons for poor response to treatment of posttraumatic reflex symptathetic dystrophy. Acta-Orthop-Belg 1998, 64:309-313.
31. Koke AJ, Schouten JS, Lamerichs-Geelen MJ, Lipsch JS, Waltje EM, van Kleef M, Patijn J: Pain reducing effect of three types of transcutaneous electrical nerve stimulation in patients with chronic pain: A randomized crossover trial. Pain 2004, 108:36-42.
32. Merskey H, Bogduk N: Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms 2nd edition. Seattle: IASP Press; 1994.
33. Galer B, Jensen M: Development and preliminary validation of a pain measure specific to neuropathic pain: The neuropathic pain scale. Neurology 1997, 48:332-338.
34. Kemler M, Schouten H, Gracely R: Diagnosing sensory abnormalities with either normal values or values from contralateral skin: Comparison of two approaches in complex regional pain syndrome i. Anesthesiology 2000, 93:718-727.
35. Ochoa J, Yarnitzky D: Mechanical hyperalgesias in neuropathic pain patients: Dynamic and static subtypes. Ann Neurol 1993, 33:465-472.
36. Oerlemans H, Oostendorp R, de Boo T, Perez R, Goris R: Signs and symptoms in complex regional pain syndrome type i/reflex sympathetic dystrophy: Judgment of the physician versus objective measurement. Clin J Pain 1999, 15:224-232.
37. Arrindell W, Attema J: Scl-90 handleiding bij een multidimensionele psychopathologie indicatie. Lisse: Swets & Zeitlinger B.V 1986.
38. Galer B, Henderson J, Perander J, Jensen M: Course of symptoms and quality of life measurement in complex regional pain syndrome: A pilot survey. J Pain Symptom Manage 2000, 20: 86-292.
39. Schouten H: The mean difference between paired observations in crossover [het gemiddelde verschil tussen gepaarde waarnemingen in een kruisproef]. In: Een praktische inleiding in methodologie en analyse 1995:79-83.
40. Kemler MA, de Vet HC: Does randomization introduce bias in unblinded trials? Epidemiology 2000, 11:228.
41. Moulin DE, Iezzi A, Amireh R, Sharpe WK, Boyd D, Merskey H: Randomised trial of oral morphine for chronic non-cancer pain. Lancet 1996, 347:143-147.
42. Fields H: Pain modulation: Expectation, opioid analgesia and virtual pain. Prog Brain Res 2000, 122:245-253.
43. Chong M, Smith T, Hanna M: Case reports - reversal of sensory deficit associated with pain relief after treatment with gabapentin. Pain 2002, 96:329-333.
44. Verdugo R, Ochoa J: Reversal of hypoaesthesia by nerve block, or placebo: A psychologically mediated sign in chronic pseudoneuropathic pain patients. J Neurol Neurosurg Psychiatry 1998, 65:196-203.
45. Filadora VA 2nd, Sist TC, Lema MJ: Acute herpetic neuralgia and postherpetic neuralgia in the head and neck: Response to gabapentin in five cases. Reg Anesth Pain Med 1999, 24: 70-174.